SUNNYVALE, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Cerebras Systems Inc. (“Cerebras”) today announced the pricing of its initial public offering of an aggregate of…
Mobia Medical Announces Pricing of Initial Public Offering
AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) — Mobia Medical, Inc. (Nasdaq: MOBI) (“Mobia Medical”), a commercial-stage medical device company redefining stroke recovery for survivors…
Avalyn Announces Pricing of Upsized Initial Public Offering
BOSTON, April 29, 2026 (GLOBE NEWSWIRE) — Avalyn Pharma Inc. (Nasdaq: AVLN) (“Avalyn”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm…
SOLV Energy Announces Pricing of Initial Public Offering
SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) — SOLV Energy, Inc. (“SOLV” or the “Company”), a leading provider of infrastructure services to the power industry,…
EquipmentShare Prices Initial Public Offering
COLUMBIA, Mo., Jan. 22, 2026 (GLOBE NEWSWIRE) — EquipmentShare.com Inc (“EquipmentShare”), a leader in connected jobsite technology and one of the largest equipment rental providers…
Wealthfront Announces Pricing of Initial Public Offering
PALO ALTO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Wealthfront, a tech-driven financial platform helping digital natives turn their savings into wealth, today announced the…
Wealthfront Announces Launch of Initial Public Offering
PALO ALTO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — Wealthfront, a tech-driven financial platform helping digital natives turn their savings into wealth, today announced that…
BillionToOne Announces Pricing of Upsized Initial Public Offering
MENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company with a mission to create powerful and accurate…
MapLight Therapeutics Announces Pricing of Initial Public Offering
SAN FRANCISCO and BOSTON, Oct. 26, 2025 (GLOBE NEWSWIRE) — MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering…
Central Bancompany, Inc. Files Registration Statement for Proposed Initial Public Offering
Central Bancompany, Inc. Files Registration Statement for Proposed Initial Public Offering Source: Central Bancompany, Inc. Files Registration Statement for Proposed Initial Public Offering
Black Rock Coffee Bar Announces Pricing of Initial Public Offering
SCOTTSDALE, Ariz., Sept. 11, 2025 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, Inc. (“Black Rock Coffee Bar”) today announced the pricing of the initial public…
CapsoVision Announces Pricing of Initial Public Offering
SARATOGA, Calif., July 01, 2025 (GLOBE NEWSWIRE) — CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”)…
Jefferson Capital Announces Pricing of Initial Public Offering
MINNEAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) — Jefferson Capital, Inc. (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off and insolvency consumer accounts,…
Aardvark Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to…
Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
BOSTON, Feb. 10, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm…
Sionna Therapeutics Prices Upsized Initial Public Offering
BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) — Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm…
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering
IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the…
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesity Source: BioAge Labs Reports Third Quarter 2024 Financial Results and Provides…
WeRide Inc. Announces Pricing of Initial Public Offering
NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) — WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD), a global leader and a first mover in the…
Septerna Prices Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) — Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled…